FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021801801> ?p ?o ?g. }

• W2021801801 endingPage "753" @default.
• W2021801801 startingPage "744" @default.
• W2021801801 abstract "Abstract In the past 25 years, the worldwide AIDS epidemic has grown such that roughly 38 million people were estimated to be living with the disease worldwide at the end of 2003. The introduction of antiretroviral‐based therapies, beginning in 1987, has enabled many to live with HIV as a chronic, rather than terminal, disease. However, the emergence and spread of drug‐resistant strains highlights the continued need for new therapies with novel modes of action. In 2003, the FDA and EMEA approved enfuvirtide (Fuzeon), a 36 amino acid peptide derived from the natural gp41 HR2 sequence, as the first HIV fusion inhibitor. T‐1249, a 39 amino acid fusion inhibitor, is active against viruses that develop resistance to enfuvirtide. The development of FIs and the processes to manufacture enfuvirtide and T‐1249 on an unprecedented scale for peptide therapeutics are presented. Synthetic routes based on a combination of solid phase peptide synthesis and solution phase fragment condensation as well as the analytical controls necessary to insure a robust process are discussed. Copyright © 2005 European Peptide Society and John Wiley & Sons, Ltd." @default.
• W2021801801 created "2016-06-24" @default.
• W2021801801 creator A5005515392 @default.
• W2021801801 creator A5006160293 @default.
• W2021801801 creator A5006596306 @default.
• W2021801801 creator A5011274637 @default.
• W2021801801 creator A5019042158 @default.
• W2021801801 creator A5028094763 @default.
• W2021801801 creator A5031278766 @default.
• W2021801801 creator A5034801183 @default.
• W2021801801 creator A5037160439 @default.
• W2021801801 creator A5048563759 @default.
• W2021801801 creator A5064767143 @default.
• W2021801801 creator A5070754198 @default.
• W2021801801 creator A5071499636 @default.
• W2021801801 creator A5084380254 @default.
• W2021801801 date "2005-08-30" @default.
• W2021801801 modified "2023-10-15" @default.
• W2021801801 title "Development of HIV fusion inhibitors" @default.
• W2021801801 cites W1529818809 @default.
• W2021801801 cites W1542320852 @default.
• W2021801801 cites W1859737084 @default.
• W2021801801 cites W1963804476 @default.
• W2021801801 cites W1990332976 @default.
• W2021801801 cites W2003760111 @default.
• W2021801801 cites W2026570047 @default.
• W2021801801 cites W2034073194 @default.
• W2021801801 cites W2050621055 @default.
• W2021801801 cites W2055429514 @default.
• W2021801801 cites W2062076639 @default.
• W2021801801 cites W2064492827 @default.
• W2021801801 cites W2085739552 @default.
• W2021801801 cites W2095613131 @default.
• W2021801801 cites W2107672429 @default.
• W2021801801 cites W2107773522 @default.
• W2021801801 cites W2112082353 @default.
• W2021801801 cites W2124409966 @default.
• W2021801801 cites W2133649749 @default.
• W2021801801 cites W2135072010 @default.
• W2021801801 cites W2167278859 @default.
• W2021801801 cites W2169623461 @default.
• W2021801801 cites W4232678588 @default.
• W2021801801 doi "https://doi.org/10.1002/psc.703" @default.
• W2021801801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16130177" @default.
• W2021801801 hasPublicationYear "2005" @default.
• W2021801801 type Work @default.
• W2021801801 sameAs 2021801801 @default.
• W2021801801 citedByCount "44" @default.
• W2021801801 countsByYear W20218018012012 @default.
• W2021801801 countsByYear W20218018012013 @default.
• W2021801801 countsByYear W20218018012014 @default.
• W2021801801 countsByYear W20218018012015 @default.
• W2021801801 countsByYear W20218018012018 @default.
• W2021801801 countsByYear W20218018012021 @default.
• W2021801801 countsByYear W20218018012022 @default.
• W2021801801 countsByYear W20218018012023 @default.
• W2021801801 crossrefType "journal-article" @default.
• W2021801801 hasAuthorship W2021801801A5005515392 @default.
• W2021801801 hasAuthorship W2021801801A5006160293 @default.
• W2021801801 hasAuthorship W2021801801A5006596306 @default.
• W2021801801 hasAuthorship W2021801801A5011274637 @default.
• W2021801801 hasAuthorship W2021801801A5019042158 @default.
• W2021801801 hasAuthorship W2021801801A5028094763 @default.
• W2021801801 hasAuthorship W2021801801A5031278766 @default.
• W2021801801 hasAuthorship W2021801801A5034801183 @default.
• W2021801801 hasAuthorship W2021801801A5037160439 @default.
• W2021801801 hasAuthorship W2021801801A5048563759 @default.
• W2021801801 hasAuthorship W2021801801A5064767143 @default.
• W2021801801 hasAuthorship W2021801801A5070754198 @default.
• W2021801801 hasAuthorship W2021801801A5071499636 @default.
• W2021801801 hasAuthorship W2021801801A5084380254 @default.
• W2021801801 hasConcept C159047783 @default.
• W2021801801 hasConcept C159654299 @default.
• W2021801801 hasConcept C185592680 @default.
• W2021801801 hasConcept C195616568 @default.
• W2021801801 hasConcept C203014093 @default.
• W2021801801 hasConcept C2776258796 @default.
• W2021801801 hasConcept C2778037500 @default.
• W2021801801 hasConcept C2779281246 @default.
• W2021801801 hasConcept C3013748606 @default.
• W2021801801 hasConcept C55493867 @default.
• W2021801801 hasConcept C71924100 @default.
• W2021801801 hasConcept C98274493 @default.
• W2021801801 hasConceptScore W2021801801C159047783 @default.
• W2021801801 hasConceptScore W2021801801C159654299 @default.
• W2021801801 hasConceptScore W2021801801C185592680 @default.
• W2021801801 hasConceptScore W2021801801C195616568 @default.
• W2021801801 hasConceptScore W2021801801C203014093 @default.
• W2021801801 hasConceptScore W2021801801C2776258796 @default.
• W2021801801 hasConceptScore W2021801801C2778037500 @default.
• W2021801801 hasConceptScore W2021801801C2779281246 @default.
• W2021801801 hasConceptScore W2021801801C3013748606 @default.
• W2021801801 hasConceptScore W2021801801C55493867 @default.
• W2021801801 hasConceptScore W2021801801C71924100 @default.
• W2021801801 hasConceptScore W2021801801C98274493 @default.
• W2021801801 hasIssue "11" @default.
• W2021801801 hasLocation W20218018011 @default.
• W2021801801 hasLocation W20218018012 @default.

• next